Li-Tian Yin Selected Research

Toxoplasma gondii phosphoglycerate mutase 2

1/2016

Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Tian Yin Research Topics

Disease

7	Toxoplasmosis 01/2016 - 01/2013
3	Glioma (Gliomas) 10/2007 - 09/2006
2	Infections 01/2016 - 01/2016
2	Brain Neoplasms (Brain Tumor) 01/2010 - 10/2007
1	Necrosis 01/2022
1	Hyperalgesia 01/2022
1	Neoplasms (Cancer) 10/2007

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 01/2016 - 01/2013
2	Peptides (Polypeptides)IBA 01/2015 - 09/2006
2	Chloride Channels (Chloride Channel)IBA 10/2007 - 01/2007
2	ChlorotoxinIBA 01/2007 - 09/2006
1	Formaldehyde (Formol)FDA Link 01/2022
1	CytokinesIBA 01/2022
1	Toxoplasma gondii phosphoglycerate mutase 2IBA 01/2016
1	AntigensIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	A-Form DNA (A-DNA)IBA 01/2016
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2015
1	Toxoplasma gondii rhoptry protein 17IBA 01/2014
1	Protein Disulfide-IsomerasesIBA 01/2013
1	Temozolomide (Temodar)FDA LinkGeneric 10/2007
1	Ion Channels (Ion Channel)IBA 10/2007
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 10/2007
1	VenomsIBA 01/2007
1	NeurotoxinsIBA 01/2007
1	Proteins (Proteins, Gene)FDA Link 09/2006

Therapy/Procedure

2	Therapeutics 01/2010 - 10/2007
1	Drug Therapy (Chemotherapy) 10/2007